Dazodalibep
Horizon Therapeutics
['dazodalibep', 'horizon thera', '$hznp']
$hznp horizon therapeutics plc - presentations at the 2023 eular european congress of rheumatology highlight new results from phase 2 trial evaluating dazodalibep in sjogren's syndrome | marketscreener 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities